RLYB Stock, Rallybio Corporation Information
Stock Information
Get RLYB Alerts
News, Short Squeeze, Breakout and More Instantly...
About Rallybio Corporation
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.